Doloforte

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Doloforte

Property Description
Active Ingredient Ibuprofen
Pharmacological Class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common Use Relief of pain, inflammation, and fever
Forms Tablet, Capsule, Suspension, Gel
Origin Synthetic compound

Doloforte is a medicinal product defined by its active pharmaceutical ingredient, Ibuprofen. It belongs to the high-level class of Nonsteroidal Anti-inflammatory Drugs (NSAIDs), a therapeutic category recognized for its triple action: reducing pain, fighting inflammation, and lowering elevated body temperature. This medication is a synthetic compound derived from propionic acid and functions as a single-component therapy.


Defining Doloforte: Classification and Active Ingredient

Doloforte is classified within the propionic acid derivative subclass of NSAIDs, making it chemically distinct from other analgesic agents such as paracetamol. The core active compound is Ibuprofen (INN), which is produced via a controlled chemical process. Ibuprofen functions by inhibiting key enzymes, supporting its role as a multipurpose agent for symptomatic relief. This means the medication helps lessen discomfort by targeting the biological processes that cause pain and swelling rather than merely masking the sensation.


Forms, Types, and General Purpose

The general purpose of Doloforte is to provide fundamental relief from symptoms related to mild to moderate pain, inflammation, and fever, such as discomfort commonly associated with muscle strain. The active substance is available in various dosage forms, including the common oral tablet or capsule, as well as suspensions and specialized topical gels. These forms allow for administration via the oral route for systemic effects or the topical route for targeted application. Ibuprofen is an established agent for these uses across diverse patient populations. This profile relates to the drug's role in providing foundational symptomatic support for numerous common conditions.

Regulatory References

  1. Ibuprofen - StatPearls - NCBI Bookshelf - NIH

What side effects are possible with Doloforte?

The official safety profile of Doloforte (Ibuprofen) is structured by government regulatory agencies through classifications that define the nature, severity, and context of possible adverse reactions. Adverse effects are grouped by system-organ classes, with Gastrointestinal Disorders (e.g., dyspepsia, nausea, abdominal pain) and Nervous System Disorders (e.g., headache, dizziness) being among the most common adverse reactions listed in regulatory documents.

Serious Adverse Reactions

The regulatory labeling documents specific, serious adverse reactions that can be fatal. These include Cardiovascular Thrombotic Events (such as myocardial infarction and stroke) and Serious Gastrointestinal Events (including bleeding, ulceration, and perforation of the stomach or intestines). Other serious reactions include severe cutaneous adverse reactions (SCARs) and anaphylaxis.

Safety Patterns and Restrictions

Risk is officially associated with exposure factors: the risk of serious gastrointestinal events increases with longer duration of use, and cardiovascular risk is noted as potentially increased at high dosages (at or above 2400 mg/day). The medicine is formally contraindicated for pain management following Coronary Artery Bypass Graft (CABG) surgery and in patients with active peptic ulceration or severe renal, hepatic, or heart failure. Population-specific safety notes advise that older adults have a greater risk of serious GI and renal events, and use is contraindicated in the third trimester of pregnancy due to the risk of premature closure of the fetal ductus arteriosus.

Regulatory Summary

This structure ensures focus on critical potential outcomes and formally sets the boundaries for use, establishing that the drug may also mask signs of infection, potentially delaying diagnosis.

Overdose and Emergency Response

Overdose and When to Seek Help

Official Overdose Profile

Overdose of Doloforte, which contains Ibuprofen, is associated with a range of documented manifestations, primarily affecting the gastrointestinal and central nervous systems. Common clinical signs include nausea, vomiting, and abdominal pain, alongside CNS effects such as drowsiness, lethargy, and dizziness.

Severe or life-threatening outcomes can occur following a significant ingestion. These high-risk manifestations documented in regulatory summaries include convulsions, coma, hypotension (low blood pressure), and the potential onset of acute renal failure. Regulatory summaries also note that young children are considered a population more susceptible to severe CNS toxicity, such as seizures, in overdose situations.


Emergency Response and Management

Regulatory authorities mandate that individuals seek immediate medical attention and contact a Poison Control Center immediately for any suspected overdose or ingestion of excessive amounts, regardless of current symptoms. The necessary treatment is symptomatic and supportive, as official documentation confirms that no specific antidote is known for Ibuprofen toxicity. Procedural measures described may include administration of activated charcoal or gastric lavage, alongside necessary correction of fluid and electrolyte imbalances.

Therapeutic Uses of Doloforte

Doloforte is indicated for the management of mild to moderate pain. It may provide relief for pain associated with minor injuries such as sprains and strains, as well as common headaches and toothaches. Additionally, the medication is used in the temporary management of fever and its associated symptoms. Chronic conditions like mild arthritis and back pain may also respond to treatment with Doloforte, potentially supporting an improved range of motion and functional capacity.

Quick Fact: Relief for Mild to Moderate Pain

The primary clinical scenarios for use often involve managing discomfort after minor procedures or addressing the everyday pain of common inflammatory conditions. This may help patients maintain their daily activities with greater ease.

Eligibility and Restrictions for Use

Absolute Contraindications

Doloforte is strictly prohibited for use in several populations as defined by regulatory bodies. This includes individuals with confirmed hypersensitivity to ibuprofen, aspirin, or any other Nonsteroidal Anti-inflammatory Drug (NSAID). Use is contraindicated for patients with active gastrointestinal bleeding or a history of perforation linked to previous NSAID use. Severe organ impairment is an exclusion: the medicine is prohibited in patients with severe heart failure (NYHA Class IV) or severe renal failure. Furthermore, use is contraindicated for the management of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery.


Age and Developmental Restrictions

Doloforte is generally approved for adults and adolescents (12 years and older). Many oral formulations are not recommended for infants under six months of age due to insufficient data. Use is contraindicated for pregnant individuals from 20 weeks of gestation onward. For the first and second trimesters, use is not recommended unless considered clearly necessary. Use in older adults requires caution due to an increased susceptibility to adverse effects, and lower doses are often required.


Conditional Use

Use is restricted and requires caution in populations with moderate hepatic or renal impairment, a history of gastrointestinal disease (such as Crohn's disease), or pre-existing cardiovascular conditions, including uncontrolled hypertension.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Doloforte (Ibuprofen) has officially documented interaction patterns based on regulatory labeling. Co-administration with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including COX-2 selective inhibitors, is formally contraindicated. This prohibition also extends to Acetylsalicylic Acid (Aspirin) doses exceeding 75 mg daily. Pharmacodynamic interactions are noted to increase the risk of gastrointestinal bleeding when combined with substances like Antiplatelet Agents or SSRIs. Furthermore, Ibuprofen may reduce the antihypertensive effect of medicines such as ACE inhibitors, and combined use with Diuretics carries an increased risk of nephrotoxicity.

Significant pharmacokinetic interactions are defined by regulatory documents. Ibuprofen decreases the elimination of substances like Lithium, leading to increased plasma concentrations, and reduces the clearance of Methotrexate by inhibiting its tubular secretion. For patients taking low-dose immediate-release Aspirin for cardioprotection, official labeling mandates a timing separation: Doloforte must be taken at least 30 minutes or more after aspirin, or 8 hours or more before aspirin. The regulatory profile also notes that the risk of stomach bleeding is officially increased by co-ingestion of Alcohol (Ethanol). Finally, populations with Impaired Renal Function or the Elderly are officially cited as being at greater risk of NSAID-induced renal adverse events when also using diuretics.

Mechanism of Action

How Doloforte Works

Doloforte's mechanism is centered on the reversible modulation of prostaglandin synthesis, which is the biochemical cascade influencing nociceptive and thermoregulatory signaling. Its action is initiated by the non-selective, reversible inhibition of the Cyclooxygenase (COX) enzymes (COX-1 and COX-2). This molecular action prevents the conversion of arachidonic acid into prostaglandins and other eicosanoids, which are lipid mediators mediating inflammatory and febrile physiological processes.

By suppressing prostaglandin synthesis at the site of tissue changes, the drug dampens the overactive humoral signaling that influences nociceptive signaling and local tissue response. The reduced presence of these mediators limits local vasodilation and decreases edema formation. Concurrently, it critically lowers the sensitization of peripheral nociceptors (pain fibers), modulating nociceptive signal transmission to the central nervous system.

The mechanism also involves a central component: the suppression of PGE2 synthesis within the hypothalamus, the brain's internal thermostat. This action effectively modulates the elevated hypothalamic set-point, leading to the activation of heat-dissipating mechanisms (e.g., peripheral blood flow changes) that facilitate peripheral heat dissipation mechanisms.

Dosage and Administration Information

How to Use Doloforte (Tramadol/Paracetamol)

Doloforte, a fixed-dose combination of tramadol hydrochloride and paracetamol (acetaminophen), is used according to established administration protocols. This information outlines the administration for the immediate-release oral tablet formulation.


Dosing and Administration

Guideline Instruction
Route Oral (by mouth).
Starting Dose Two (2) tablets for adults and adolescents 12 years of age or older.
Maximum Daily Dose Do not exceed eight (8) tablets (equivalent to 300 mg Tramadol / 2600 mg Paracetamol) in a 24-hour period.
Dosing Interval The minimum time between doses must be 6 hours.
Administration Method Swallow the tablets whole with liquid; do not crush or chew. May be taken with or without food.

Special Population Requirements

Dosage adjustments are required for certain patient groups to ensure proper use and to prevent accumulation of the active ingredients.

  • Severe Renal Impairment (Creatinine clearance < 30 mL/min): The dosing interval is extended to 12 hours. The maximum dose should not exceed four (4) tablets in a 24-hour period.
  • Elderly Patients (75 years of age or older): Dosing intervals may need to be prolonged due to the potential for delayed excretion of tramadol.
  • Course Duration: Use should be limited to the shortest time necessary. Do not use continuously without medical supervision.

This information describes the parameters for the medicine’s intended use.

Recent Clinical Evidence

The clinical evaluation of Doloforte, which contains the active ingredient Ibuprofen, involves numerous studies that have been conducted over a long period. This overview describes the structure of the available research, without offering clinical advice or guidance.


Evidence for Acute Pain Relief and Fever

The research base for short-term symptom patterns, such as acute pain and fever, relies on numerous Randomized Controlled Trials (RCTs) and Meta-analyses. For acute pain, studies examined outcomes related to physical discomfort, including measuring changes in pain intensity scores. For fever, trials monitored the change in body temperature in both adult and pediatric populations. Findings describe patterns of short-duration outcomes consistent with the nature of these conditions, often comparing Ibuprofen with other common agents. What remains uncertain is the research scope for severe acute pain and the relationship between temperature change and long-term clinical outcomes.


Evidence for Inflammatory Symptom Patterns

The evidence related to symptom patterns in inflammatory conditions (e.g., mild arthritis) is derived from RCTs and larger, longer-duration Observational Cohort Studies. Study outcomes examined included measures of joint function (e.g., stiffness and localized pain) and patient-reported global assessments. While these studies documented measured changes in physical function scores, the evidence is limited regarding structural or long-term disease-modifying outcomes in chronic conditions.


Key Research Gaps and Unanswered Questions

Most core evidence relies on trials where follow-up durations were limited to hours or days. The resulting limited information means evidence is primarily confined to describing group patterns, not predicting individual long-term outcomes. Data for certain groups, such as older adult populations with multiple comorbidities, remain insufficient. Research is substantial for short-term patterns but indicates that long-term patterns of chronic symptoms are not fully established.

Frequently Asked Questions (FAQ)

Common questions about Doloforte (FAQ)


Q: How quickly does Doloforte usually start working?

According to official product information, the active ingredient in Doloforte is typically absorbed rapidly after being taken by mouth. It usually reaches its peak concentration in the bloodstream within 1 to 2 hours, depending on the specific formulation. This absorption profile supports its designation for the short-term relief of symptoms like pain and fever.


Q: If I miss a dose of Doloforte, what generally happens?

Regulatory guidance emphasizes that the minimum required time interval (often 6 hours) between doses must be maintained. Official guidance on managing a missed dose states that it can be taken when remembered, provided the minimum time interval between doses is maintained and the maximum daily amount is not exceeded.


Q: Can Doloforte cause weight gain or loss?

Official adverse reaction reports occasionally mention related metabolic side effects, such as fluid retention or edema (swelling), which can sometimes be associated with a change in weight. However, this is not listed as a primary or universal side effect of the medicine.


Q: Are there any common interactions between Doloforte and common over-the-counter medicines?

Regulatory documents explicitly state that the co-administration of Doloforte with other nonsteroidal anti-inflammatory drugs (NSAIDs) or high-dose aspirin (over 75 mg per day) is officially contraindicated. This prohibition is based on regulatory findings that co-administration may increase the likelihood of certain adverse effects.


Q: Does Doloforte affect my ability to drive or operate machinery?

The official labeling indicates that the medicine can cause side effects like dizziness, fatigue, or drowsiness in some individuals. The potential for these nervous system effects means that individuals who experience them may be advised to exercise caution when driving or operating complex machinery.


Q: Is it common to feel tired when first taking Doloforte?

Official labeling, which catalogs reported adverse reactions, sometimes includes reports of somnolence (drowsiness) and a general feeling of tiredness or weakness. If a person experiences excessive tiredness, this is one of the documented nervous system reactions reported in regulatory summaries.


Q: What happens if you stop taking Doloforte suddenly?

As this medicine is not an opioid or controlled substance, its official labeling does not include warnings about dependence or withdrawal. However, discontinuing use can result in the return of the pain, inflammation, or fever symptoms the medicine was being used to address.


Q: Are there different strengths or versions of the Doloforte medicine?

The active ingredient in Doloforte, Ibuprofen, is available in various strengths and multiple dosage forms, which include oral tablets, capsules, and liquid suspensions. The specific strength prescribed is based on the use conditions.


Q: Is there a generic version of Doloforte available?

The medicine is a brand name product whose active ingredient is Ibuprofen. Ibuprofen is the internationally recognized non-proprietary name for the drug and is widely available generically.


Q: Is Doloforte a controlled substance?

According to the official drug classification schedule used by regulatory bodies, Doloforte, which contains Ibuprofen, is classified as a non-scheduled drug. This means it is not considered a controlled substance.


Q: Can Doloforte interact with vitamins or mineral supplements?

Official product information is primarily focused on mandatory warnings regarding interactions with other prescription medications and alcohol. The labeling does not typically provide a comprehensive list or specific warnings related to all possible over-the-counter vitamins or mineral supplements.


Q: Why do some people say Doloforte didn't work for them?

Clinical studies generally describe average results across large groups of patients. Official information acknowledges that effectiveness can vary widely between individuals due to unique factors such as their metabolism, the severity of their condition, and individual biological differences in pain response.


Q: Is it okay to drink coffee while taking Doloforte?

Regulatory documents specifically list contraindications with alcohol and other drugs, but coffee or caffeine is not listed in the official labeling as a required restriction or known major interaction.


Q: Can pregnant or breastfeeding people use Doloforte?

Official documentation indicates that use of the drug is contraindicated (strictly prohibited) from 20 weeks of pregnancy onward. For the first and second trimesters, use is generally not recommended unless a healthcare professional deems it clearly necessary. Official product information suggests consulting a healthcare provider for specific guidance regarding use while breastfeeding.


Q: What is the shelf life of Doloforte before it expires?

The manufacturer is required by official regulations to print an expiration date on the product packaging. This date represents the period until the manufacturer guarantees the product will maintain its potency and safety when stored under the specified conditions.


Q: Does taking Doloforte at night cause sleep disturbances?

As part of its listed nervous system adverse reactions, official labeling reports certain side effects that could potentially affect sleep, such as insomnia (trouble sleeping) or feelings of nervousness.


Q: What should I do if I get mild stomach upset from Doloforte?

Gastrointestinal side effects, such as nausea or stomach upset, are listed in regulatory documents as common adverse reactions. Official documentation notes that administration of the medicine with food is a method that may help to reduce the occurrence of gastrointestinal side effects such as stomach upset.


Q: How does Doloforte impact heart rate or blood pressure?

Official warnings note that the medicine can lead to the onset of new high blood pressure (hypertension) or potentially worsen high blood pressure that a patient already has. The potential cardiovascular effects mean that monitoring of blood pressure may be considered by a healthcare provider during treatment.


Q: What is the potential for dependence or withdrawal with Doloforte?

Official drug classifications confirm that Doloforte is not generally associated with dependence or withdrawal symptoms. This is because it is not a controlled substance and does not possess the addictive properties associated with opioid medications.


Q: Is Doloforte often combined with other prescription medications?

The medicine is documented to interact with several classes of prescription drugs, including certain blood thinners, blood pressure medicines, and antidepressants (SSRIs). The documented interactions highlight the importance of reviewing all medications during use.


Q: What is the difference between the brand name and the generic form of Doloforte?

Doloforte is a specific brand name used for the active pharmaceutical ingredient Ibuprofen. Ibuprofen is the corresponding generic drug name that is recognized globally by regulatory authorities.


Q: Is Doloforte known to cause changes in mood or anxiety?

Some official regulatory labeling reports rare side effects in the nervous system that may include mood changes, feelings of depression, or nervousness. This is not listed among the most common adverse effects.


Q: How long does Doloforte stay in your system after the last dose?

According to the official pharmacokinetic data, the active ingredient is typically metabolized and eliminated from the body relatively quickly. The majority of the drug and its byproducts are usually cleared from the system in the urine within 24 hours of the last dose.


Q: What is the risk of allergic reaction to Doloforte?

Official regulatory warnings state that the drug is contraindicated (must not be used) if a person has a known hypersensitivity or allergic reaction to Ibuprofen or any other NSAIDs. Serious adverse reactions, including anaphylaxis, have been reported in the labeling.


Q: What kind of monitoring is recommended while on Doloforte?

Regulatory documents suggest that for patients using the medicine long-term or those with specific risk factors, monitoring of parameters such as blood pressure, kidney function, and signs of gastrointestinal bleeding may be utilized by a healthcare provider.


Q: Is it necessary to take Doloforte at the exact same time every day?

The primary focus of the official dosing guidance is ensuring the minimum time interval (such as 6 hours) between each dose is maintained, and never to exceed the maximum daily amount. This minimum interval is the critical factor, rather than strict adherence to a specific clock time.


Q: Does sun exposure become risky while taking Doloforte?

Official regulatory reports sometimes include information about the potential for photosensitizing effects for Ibuprofen, which means the medicine may cause increased skin sensitivity to sunlight. This effect is not considered common but has been documented.


Q: Are there any specific lifestyle changes recommended when starting Doloforte?

Official documentation explicitly advises patients that the risk of serious stomach bleeding is increased if the medicine is used with alcohol (ethanol). This documented interaction highlights a specific usage restriction mentioned in regulatory materials.

How should Doloforte be stored and disposed of?

How to Store and Dispose of Doloforte?

Doloforte (Ibuprofen) must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F to 77 F), as defined by regulatory documents. The medication must be protected from excessive heat (above 40 C), moisture, and must not freeze. It is required to keep the product in a tight container and always out of the sight and reach of children.

Disposal

The preferred method for discarding unused or expired Doloforte is through a drug take-back program. If a program is unavailable, the product should be mixed with an undesirable substance (like coffee grounds), sealed in a bag or container, and placed in the household trash. The medication must not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Doloforte found in:

A-Z Index: